GlassScriptPhysician profile
Lena B Nguyen
NPI 1467741728
$6,455.62
in general payments reported to CMS, 2019-2025
41 companies · $956 in 2025
The $956 reported for 2025 was more than what 90% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,158 · 2020: $368 · 2021: $1,260 · 2022: $1,462 · 2023: $727 · 2024: $525 · 2025: $956.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,920 · Consulting Fee: $175 · Education: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,920.35 |
| Consulting Fee | $175.00 |
| Education | $112.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,232.02 | 2019-2025 | |
| Mayne Pharma Commercial LLC | $783.16 | 2019-2025 | |
| Astellas Pharma US INC | $544.66 | 2019-2025 | Veozah, Myrbetriq |
| Aspira Women'S Health INC | $427.56 | 2020-2021 | |
| Gyrus Acmi, INC. | $330.00 | 2022 | |
| Coopersurgical, INC. | $316.88 | 2019-2025 | Paragard T 380a |
| Sumitomo Pharma America, INC. | $243.50 | 2023-2025 | Myfembree |
| Therapeuticsmd, INC. | $208.03 | 2019-2022 | |
| Organon LLC | $195.07 | 2021-2025 | Nexplanon |
| Becton, Dickinson and Company | $184.84 | 2019-2023 | Bd Onclarity |
| Applied Medical Resources Corporation | $175.00 | 2023 | |
| Myovant Sciences INC. | $166.01 | 2021-2022 | |
| Lilly USA, LLC | $148.49 | 2019-2024 | Jardiance, Zepbound |
| Exeltis, USA INC. | $146.92 | 2020-2025 | Slynd |
| Avion Pharmaceuticals | $125.60 | 2019-2022 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $120.46 | 2019-2022 | |
| Sage Therapeutics, LLC | $111.59 | 2020 | |
| Hologic Sales and Service, LLC | $85.77 | 2019-2025 | Aptima |
| Millicent US INC | $78.77 | 2024-2025 | Intrarosa, Femring, Femlyv |
| Merck Sharp & Dohme LLC | $75.89 | 2019-2020 | |
| Evofem Biosciences, INC. | $66.14 | 2022-2025 | Phexxi, Solosec, Phexx |
| Bayer Healthcare Pharmaceuticals INC. | $65.06 | 2019-2020 | |
| Mylan Pharmaceuticals INC. | $63.56 | 2019-2021 | |
| Idorsia Pharmaceuticals US INC | $63.24 | 2022-2024 | Quviviq |
| Ibsa Pharma INC. | $55.39 | 2023 | Tirosint, Licart |
| Biogen, INC. | $54.31 | 2025 | Zurzuvae |
| Amag Pharmaceuticals, INC. | $52.77 | 2019 | |
| Channel Medsystems, INC. | $41.08 | 2022-2023 | |
| Viiv Healthcare Company | $33.41 | 2024 | Apretude |
| Intuitive Surgical, INC. | $32.81 | 2024 | |
| Allergan, INC. | $30.98 | 2019 | |
| Agile Therapeutics, INC. | $30.18 | 2021-2022 | |
| Lupin INC. | $26.37 | 2019-2020 | |
| Exact Sciences Corporation | $24.27 | 2023 | Cologuard Collection Kit |
| Duchesnay USA Incorporated | $23.44 | 2019 | |
| Novo Nordisk INC | $19.09 | 2022 | |
| Virtus Pharmaceuticals LLC | $18.60 | 2021 | |
| Smith+Nephew, INC. | $14.25 | 2019 | |
| Pfizer INC. | $14.13 | 2019 | |
| Medicem INC. | $13.20 | 2021 | |
| Meditrina | $13.12 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lena Nguyen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.